Share Repurchase Plan Declared by Neurocrine Biosciences (NASDAQ:NBIX) Board of Directors
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) announced that its Board of Directors has authorized a stock repurchase plan on Friday, February 21st, RTT News reports. The company plans to buyback $500.00 million in shares. This buyback authorization allows the company to purchase up to 4.2% of its stock through open market purchases. Stock buyback […]
Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) announced that its Board of Directors has authorized a stock repurchase plan on Friday, February 21st, RTT News reports. The company plans to buyback $500.00 million in shares. This buyback authorization allows the company to purchase up to 4.2% of its stock through open market purchases. Stock buyback […]
